Market Overview

Aegerion Pharmaceuticals Grants Stock Options to Purchase 55K Shares

Aegerion Pharmaceuticals (NASDAQ: AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering therapies for patients with debilitating and often fatal rare diseases, today announced that, on January 2, 2013, Aegerion granted stock options to purchase an aggregate of 55,000 shares of common stock to five new employees under the inducement stock option program described below. Each stock option has an exercise price per share equal to $27.24, the closing price of Aegerion's common stock on the grant date, vests in equal monthly installments over four years, has a ten year term and will be subject to the terms and conditions of a stock option agreement covering the grant.

As Aegerion previously announced, in support of the company's build of its U.S. commercial organization and international expansion, the Compensation Committee of the Company's Board of Directors approved the reservation of 1,000,000 shares of common stock to be used exclusively for the grant of non-qualified stock options to individuals who were not previously an employee or non-employee director of Aegerion (or following a bona fide period of non-employment), as an inducement new hire stock option award material to an individual's

See full press release

Posted-In: News Guidance Management

 

Related Articles (AEGR)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters